Clonidine for smoking cessation

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 12, 2004, Pages

  Gourlay, Steven G ^a   Stead, Lindsay F ^b   Benowitz, Neal ^c  

^a Department of Primary Health Care ^*  (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; PLACEBO;

BEHAVIOR THERAPY; BIOCHEMICAL ANALYSIS; CLINICAL OUTCOME; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; INCIDENCE; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEDATION; SIDE EFFECT; SMOKING CESSATION; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; TREATMENT DURATION; TREATMENT RESPONSE; VALIDATION PROCESS; XEROSTOMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SMOKING;

CLONIDINE; HUMANS; RANDOMIZED CONTROLLED TRIALS; SMOKING; SMOKING CESSATION;

EID: 16544382730     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD000058.pub2     Document Type: Review

References (38)

1. Glassman AH, Stetner F, Walsh T, Raizman PS, Fleiss J, Cooper TB, et al. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA 1988;259:2863-6.
2. Glassman AH, Covey LS, Dalack GW, Stetner F, Rivelli SK, Fleiss J, et al. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clinical Pharmacology and Therapeutics 1993;54:670-9.
3. Hao-W, Young D, Wei H. Effect of clonidine on cigarette cessation and in the alleviation of withdrawal symptoms [published erratum appears in British Journal of Addiction 1988;83:1467]. British Journal of Addiction 1988;83:1221-6.
4. Hilleman DE, Mohiuddin SM, Delcore MG, Lucas BD. Randomized, controlled trial of transdermal clonidine for smoking cessation. The Annals of Pharmacotherapy 1993;27:1025-8.
5. Niaura R, Brown RA, Goldstein MG, Murphy JK, Abrams DB. Transdermal clonidine for smoking cessation - a double-blind randomized dose-response study. Experimental and Clinical Psychopharmacology 1996;4:285-91.
6. Villagra VG. Transdermal clonidine for smoking cessation: a randomized trial. Clinical Research 1991;39:640A.
7. Villagra VG, Rosenberger JL, Girolami S. Transdermal clonidine for smoking cessation: A randomized, double blind, placebo controlled trial. Circulation 1989;80 Suppl II(4):11-58.
8. Ahmadi J, Ashkani H, Ahmadi M, Ahmadi N. Twenty-four week maintenance treatment of cigarette smoking with nicotine gum, clonidine and naltrexone. Journal of Substance Abuse Treatment 2003;24:251-5.
9. Aparici M, Fernandez Gonzalez AL, Alegria E. Clonidine in the treatment of tobacco withdrawal. Comparison with nicotine chewing gum [Clonidina en el tratamiento de la deshabituacion tabaquica. Comparacion con chicles de nicotina.]. Revista Clinica Espanol 1994;194:453-6.
10. Appel D. Clonidine helps cigarette smokers stop smoking. American Review of Respiratory Diseases 1987;135(Suppl):A354.
11. Cummings KM. A double-blind placebo controlled multi-center trial of two dosage strengths of Catapres-TTS in smoking cessation. Unpublished draft manuscript.
12. Davison R, Kaplan K, Fintel D, Parker M, Anderson L, Haring O. The effect of clonidine on the cessation of cigarette smoking. Clinical Pharmacology and Therapeutics 1988;44:265-7.
13. Franks P, Harp J, Bell B. Randomized, controlled trial of clonidine for smoking cessation in a primary care setting [comment in: JAMA 1990 May 23-30;263(20):2746-7]. JAMA 1989;262:3011-3.
14. Glassman AH, Jackson WK, Walsh BT, Roose SP, Rosenfeld B. Cigarette craving, smoking withdrawal, and clonidine. Science 1984;226:864-6.
15. Gourlay SG, Forbes A, Marriner T, Kutin J, McNeil J. A placebo-controlled study of three clonidine doses for smoking cessation. Clinical Pharmacology and Therapeutics 1994;55:64-9.
16. Grimaldi B, Demaria C, Loufrani E, Bang F, Geslin P, Lagrue G. Results of a controlled study of clonidine vs placebo for cessation of smoking [Résultats d'une étude controlée clonidine/placebo dans le sevrage tabagique]. Sem Hop Paris 1987;63:3369-70.
17. Hilleman DE, Mohiuddin SM, Malesker MA, Delcore MG, Sketch MH. Double-blind, placebo-controlled evaluation of transdermal clonidine in smoking cessation. Chest 1989;96(Suppl):208S.
18. Murray KM, Cappello C, Baez SA. Lack of efficacy of transdermal clonidine in a smoking cessation class. American Review of Respiratory Diseases 1989;139(Suppl):A338.
19. Nana A, Praditsuwan R. Clonidine for smoking cessation. Journal of the Medical Association of Thailand 1998;81:87-93.
20. Ornish SA, Zisook S, McAdams LA. Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial. Archives of Internal Medicine 1988;148:2027-31.
21. Prochazka AV, Petty TL, Nett L, Silvers GW, Sachs DPL, Rennard SI, et al. Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation. Archives of Internal Medicine 1992;152:2065-9.
22. Wu Gue-qang, et al. 'Effects of transcutaneous clonidine refraining of the nicotine addiction' [poster 311]. Abstracts of the 10th World Conference on Tobacco or Health; Aug 24-28; Beijing, China. 1997:208.
23. Bredfeldt RC, Sutherland JE, Kruse JE. Efficacy of transdermal clonidine for headache prophylaxis and reduction of narcotic use in migraine patients. Journal of Family Practice 1989;29:153-6.
24. Edington RF, Chagnon J-P, Steinburg WM. Clonidine (dixarit) for menopausal flushing. Canadain Medical Association Journal 1980;123:23-5.
25. Ginsburg J, O'Reilly B, Swinhoe J. Effect of oral clonidine on human cardiovascular responsiveness: a possible explanation of the therapeutic action of the drug in menopausal flushing and migraine. British Journal of Obstetrics and Gynaecology 1985;92:1169-75.
26. Gold MS. Opiate addiction and the locus coeruleus: The clinical utility of clonidine, naltrexone, methadone, and buprenorphine. The Psychiatric Clinics of North America 1993;16:61-73.
27. Gourlay SG, Forbes A, Marriner T, Kutin J, McNeil J. A placebo-controlled study of three clonidine doses for smoking cessation. Clinical Pharmacology and Therapeutics 1994;55:64-9.
28. Gourlay SG, Benowitz NL. Is clonidine an effective smoking cessation therapy?. Drugs 1995;50:197-207. [MEDLINE: 1996131150]
29. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD000031.pub3]
30. Imperial Cancer Research Fund General Practice Research Group. Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. BMJ 1993;306:1304-8.
31. Leckman JF, Detlor J, Harcherik DF, Ort S, Shaywitz BA, Cohen DJ. Short- and long-term treatment of Tourette's syndrome with clonidine: a clinical perspective. Neurology 1985;35:343-51.
32. Manhem P, Nilsson LH, Moberg A, Wadstein J, Hokfelt B. Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin-aldosterone system, and clinical symptoms. Alcoholism, Clinical and Experimental Research 1985;9:238-43.
33. Russell MAH, Stapleton JA, Feyerabend C, Wiseman SM, Gustavsson G, Saw U, Connor P. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ 1993;306:1308-12.
34. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD000146.pub3]
35. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. JAMA 1991;266:3133-8. [MEDLINE: 1992065541]
36. U.S. Department of Health and Human Services. The Health Consequences of Smoking - Nicotine Addiction: A report of the Surgeon General. US DHHS, 1988.
37. Gourlay SG, Stead LF, Benowitz NL. A meta-analysis of clonidine for smoking cessation. Cochrane Database of Systematic Reviews 1997, Issue 1.
38. Gourlay SG, Stead LF, Benowitz NL. Clonidine for smoking cessation. Cochrane Database of Systematic Reviews 2001, Issue 4.